295 related articles for article (PubMed ID: 16699007)
1. Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription.
Lu F; Day L; Gao SJ; Lieberman PM
J Virol; 2006 Jun; 80(11):5273-82. PubMed ID: 16699007
[TBL] [Abstract][Full Text] [Related]
2. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
3. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
4. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
[TBL] [Abstract][Full Text] [Related]
5. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency.
Lu F; Zhou J; Wiedmer A; Madden K; Yuan Y; Lieberman PM
J Virol; 2003 Nov; 77(21):11425-35. PubMed ID: 14557628
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus-encoded LANA interacts with host KAP1 to facilitate establishment of viral latency.
Sun R; Liang D; Gao Y; Lan K
J Virol; 2014 Jul; 88(13):7331-44. PubMed ID: 24741090
[TBL] [Abstract][Full Text] [Related]
7. Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters.
Izumiya Y; Algalil A; Espera JM; Miura H; Izumiya C; Inagaki T; Kumar A
J Virol; 2024 Feb; 98(2):e0138623. PubMed ID: 38240593
[TBL] [Abstract][Full Text] [Related]
8. Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation.
Mercier A; Arias C; Madrid AS; Holdorf MM; Ganem D
J Virol; 2014 Jun; 88(12):6762-77. PubMed ID: 24696474
[TBL] [Abstract][Full Text] [Related]
9. The Latency-Associated Nuclear Antigen of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Expression of SUMO/Sentrin-Specific Peptidase 6 To Facilitate Establishment of Latency.
Lin X; Sun R; Zhang F; Gao Y; Bin L; Lan K
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615201
[TBL] [Abstract][Full Text] [Related]
10. BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency.
Chen HS; De Leo A; Wang Z; Kerekovic A; Hills R; Lieberman PM
PLoS Pathog; 2017 Jan; 13(1):e1006100. PubMed ID: 28107481
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
12. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
[TBL] [Abstract][Full Text] [Related]
13. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
Li Q; He M; Zhou F; Ye F; Gao SJ
J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation.
Nakajima K-i; Inagaki T; Espera JM; Izumiya Y
J Virol; 2024 Feb; 98(2):e0126823. PubMed ID: 38240588
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
Verma SC; Lan K; Choudhuri T; Robertson ES
J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
[TBL] [Abstract][Full Text] [Related]
17. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
Wakeman BS; Izumiya Y; Speck SH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
[TBL] [Abstract][Full Text] [Related]
18. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
[TBL] [Abstract][Full Text] [Related]
19. Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1.
Viejo-Borbolla A; Ottinger M; Brüning E; Bürger A; König R; Kati E; Sheldon JA; Schulz TF
J Virol; 2005 Nov; 79(21):13618-29. PubMed ID: 16227282
[TBL] [Abstract][Full Text] [Related]
20. Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter.
Elbasani E; Falasco F; Gramolelli S; Nurminen V; Günther T; Weltner J; Balboa D; Grundhoff A; Otonkoski T; Ojala PM
Viruses; 2020 Aug; 12(9):. PubMed ID: 32867368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
